CN103257241B - New application of CRISP (cysteine-rich secretory protein)1 to medical instrument - Google Patents

New application of CRISP (cysteine-rich secretory protein)1 to medical instrument Download PDF

Info

Publication number
CN103257241B
CN103257241B CN201310191251.8A CN201310191251A CN103257241B CN 103257241 B CN103257241 B CN 103257241B CN 201310191251 A CN201310191251 A CN 201310191251A CN 103257241 B CN103257241 B CN 103257241B
Authority
CN
China
Prior art keywords
crisp1
medical instrument
carcinoma
cysteine
secretory protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310191251.8A
Other languages
Chinese (zh)
Other versions
CN103257241A (en
Inventor
朱进安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Tenth Peoples Hospital
Original Assignee
Shanghai Tenth Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Tenth Peoples Hospital filed Critical Shanghai Tenth Peoples Hospital
Priority to CN201310191251.8A priority Critical patent/CN103257241B/en
Publication of CN103257241A publication Critical patent/CN103257241A/en
Application granted granted Critical
Publication of CN103257241B publication Critical patent/CN103257241B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to an application of a CRISP (cysteine-rich secretory protein)1 to preparation of a medical instrument for diagnosing carcinoma of buccal mucosa. The medical instrument is a diagnostic test paper or kit. The diagnosis sample of the medical instrument is saliva. The invention has the advantages that a new application of the CRISP1 is provided, and a convenient, reliable, non-invasive and cheap method is provided for large-scale population screening of carcinoma of buccal mucosa and self-checking of patients after carcinoma of buccal mucosa surgery so as to guide treatment of carcinoma of buccal mucosa; and the test paper is quick in checking, has high sensitivity, strong specificity and good stability, is simple and convenient to operate, dispenses with any instrument, is intuitive and reliable in result judgment, is easy to master and is simultaneously convenient for the patients to self-monitor the conditions.

Description

The novelty teabag of a kind of CRISP1 in medicine equipment
Technical field
The present invention relates to a kind of novelty teabag of albumen, specifically, is about the novelty teabag of a kind of CRISP1 in medicine equipment.
Background technology
Cheek cancer usually means and betides carcinoma of buccal mucosa.Person habitually belongs to carcinoma of facial skin to betide skin of cheek.Cheek cancer is general without obvious pain in early days, causes patient often to incur loss through delay and seeks medical advice, and when infiltrating the deep tissues such as muscle or concurrent infection when cancerous swelling, occurs obvious pain, companion's limitation of mouth opening in various degree, until teeth clenched.After tooth surrounding tissue is got involved, toothache or odontoseisis can be there is.Due to cancer knurl infiltrate ulcer formed, particularly occur together infect time, can cause local secondary hemorrhage, pain increases the weight of.Patient often has submandibular lymph nodes to increase.Lymphadenovaris may, due to cancer tumor metastasis, also may be caused by infection.Because cheek cancer is infiltrative growth, local relapse is high, and except infiltration is shown shallow limitation cheek mucous membrane cancer can be considered to adopt simple freezing and radiotherapy among a small circle, centering patients with terminal, at present advocates to adopt the complex treatment based on operation more.
Summary of the invention
The object of the invention is for deficiency of the prior art, provide a kind of and be rich in the application of cysteine secretory protein 1 in the medicine equipment of preparation diagnosis cheek cancer.
For achieving the above object, the technical scheme that the present invention takes is: a kind of cysteine secretory protein 1 that is rich in is preparing the application in the medicine equipment diagnosing cheek cancer, described medicine equipment is diagnose test paper or kit, and the diagnosis sample of described medicine equipment is saliva.
The diagnosis threshold of described medicine equipment is that saliva is rich in cysteine secretory protein 1 concentration 10-40ng/ml.
The invention has the advantages that: provide the novelty teabag being rich in cysteine secretory protein 1, for the large-scale crowd examination of cheek cancer, oneself's detection of cheek cancer postoperative patient are provided convenience, reliably, without wound, inexpensive method, instructed the treatment of cheek cancer; Detection paper of the present invention is quick, highly sensitive, high specificity, good stability, easy and simple to handle, without the need to any instrument and equipment, and result judge intuitive and reliable, be easy to grasp, simultaneously also facilitate patient to state of an illness self-monitoring.
Accompanying drawing explanation
Accompanying drawing 1 is the structural representation of the CRISP1 diagnose test paper of cheek cancer.
Accompanying drawing 2 is testing result schematic diagrames of the CRISP1 diagnose test paper of cheek cancer.
Accompanying drawing 3 is testing process schematic diagrames of the CRISP1 diagnose test paper of cheek cancer.
Detailed description of the invention
Below detailed description of the invention provided by the invention is elaborated.
Embodiment 1
Below in conjunction with accompanying drawing, detailed description of the invention provided by the invention is elaborated.
The Reference numeral related in accompanying drawing and part as follows:
1. base plate 2. sample pad
3. gold size pad 4. cellulose nitrate rete
5. absorbent paper layer 6. saliva
7. chromatography direction
Embodiment 1 SABC
Experiment material: normal BT, cheek cancerous tissue; Primary antibodie is goat-anti people CRISP1 antibody, two anti-donkeys anti-sheep Dylight594 antibody.
Experimental technique:
A large amount of tissue sample is combined in a small substrate surface by organization chip exactly in an orderly manner, detects by immunohistochemical method.
1, tissue PFA fixer is fixed 5 minutes, PBS washes 10 minutes
2, antigen retrieval: expose epiope with 0.01M citrate solution.The heating in 3 minutes of the high fire of micro-wave oven repairs liquid to boiling (4 minutes), then 1 minute, twice, continuous low fiery microwave.Be cooled to room temperature, PBS washes 10 minutes.Triton rupture of membranes with 0.5% 10 minutes.
3, nonspecific proteins is closed
1) PBS soaks 3 minutes × 3 times
2) 3% H 2o 2-methyl alcohol (30% H 2o 210ml+ methyl alcohol 90ml) soaking at room temperature 30 minutes
3) tap water 10 minutes, PBS soaks 3 minutes × 3 times, and drying or paper handkerchief suck surplus liquid (not encountering tissue), draws circle (prepare 10% in the distilled water flushing time and close serum) with groupization pen around tissue
4) in circle inner tissue, instillation 5% BSA(PBS prepares rapidly), close heterogenetic antigen (do not allow tissue dry, should add immediately after paper handkerchief sops up water), room temperature 30 minutes (preparing primary antibodie), deducts confining liquid, does not wash.
4, primary antibodie is hatched
Get rid of the BSA in section, dry residual BSA around tissue with filter paper, directly add the goat-anti people CRISP1 antibody (about 60 μ l) diluted, put into 4 DEG C, wet box and spend the night.Within second day, take out from refrigerator and need 37 DEG C of rewarming 30 min.
5, two anti-to hatch
1) primary antibodie is washed off, slide is inserted plastic slide frame, then wholely put into plastic casing, add PBS and soak to be put on microoscillator and wash 10 minutes.
2) with filter paper, the water around circle is sucked, add two anti-donkeys anti-sheep Dylight594 antibody, room temperature 30 minutes.
3) add PBS to soak and be put on microoscillator and wash 10 minutes.
6, mounting
Surplus liquid absorbed by paper handkerchief, and on slide, dropper drips DAPI mounting liquid one, and then covered, extrudes gently with tweezers, and drives bubble away, and room temperature places 1 hour.Observe.
Experimental result, organization chip immunohistochemical staining display CRISP1 secretory protein is obviously positive in 23 of 30 cheek cancerous tissues, and is negative in the normal tissue.
Embodiment 2 enzyme-linked immunosorbent assay (Elisa)
Overall totally 90 examples, wherein cheek cancer (squamous cell carcinoma) case group 30 example; Oral cavity other diseases (periodontosis, dental pulp disease, thrush) organizes 30 examples; Normal healthy controls crowd 30 example.Employing is rich in cysteine secretory protein detection kit and is detected, and detecting step is with reference to being rich in cysteine secretory protein quantitative enzyme link detection reagent kit operation instructions.
The ELISA testing result of CRISP1:
1. cheek cancer group is higher than other two groups, and other diseases group and Healthy People group indifference (P=0.802).
Table 1 saliva CRISP1 diagnoses the diagnostic value of cheek cancer
Diagnosis index AUC Sensitivity Specificity False positive rate False negative rate Youden index
Urine CRISP1 10 ng/ml 0.808 88.2% 38.3% 59.7% 11.7% 0.265
Urine CRISP1 40 ng/ml 0.808 72.3% 85.2% 11.9% 28.6% 0.575
(illustrate: area under AUC:ROC curve (Receiver operating curve); AUC, more close to 1, illustrates that diagnosis effect is better; AUC has lower accuracy 0.5 ~ 0.7 time, and AUC has certain accuracy 0.7 ~ 0.9 time, has high accuracy when AUC is more than 0.9.Youden index: youden index=sensitivity+specificity-1; It is excellent diagnostics dividing value that Youden index reaches maximum corresponding value.)
The diagnostic value of saliva CRISP1 to cheek cancer is high, and its AUC reaches 0.808.With CRISP1 10ng/ml for diagnostic threshold, it is 88.2% to the diagnostic sensitivity of cheek cancer, and specificity is 38.3%, and false positive rate is 59.7%, and false negative rate is 11.7%; With CRISP1 40 ng/ml for diagnostic threshold, its sensitivity is 72.3%, and specificity is 85.2%, and false positive rate is 11.9%, and false negative rate is 28.6%.Saliva CRISP1 concentration 40 ng/ml is excellent diagnostics dividing value; Saliva CRISP1 concentration 10 ng/ml can be used for screening object.
Embodiment 3 prepares the golden labeling antibody compound of test paper
One, collaurum preparation
The chlorauric acid solution of 100ml 0.005%-0.02% is added in round-bottomed flask and is heated to boiling, after boiling, add the trisodium citrate (Na of freshly prepared 0.4%-2% with vigorous stirring quickly and accurately 3c 6h 5o 72H 2o) aqueous solution 1-2.2ml, after boiling 10-25 minute, continues stirring and is cooled to room temperature.Can see in this process that the color change of solution is: golden yellow → black → purple → dark blue → cerise, when the color of solution becomes transparent cerise completely, i.e. obtained required collaurum.Load in bag filter after cooling and ultra-pure water (1:5000) is dialysed three times, finally the collaurum of having dialysed is transferred in the vial of clean band spiral cover, preserve under the environment of 4 DEG C of lucifuges.
Two, the connection of gold colloid and albumen
1, the absorption of collaurum to albumen depends primarily on pH value, and close under the isoelectric point of protein or the condition of meta-alkali, the two easily forms firmly bond.If during the isoelectric point of the pH value of collaurum lower than protein, then can assemble and lose binding ability.
2, the preparation of protein solution to be marked: by albumen to be marked 4 DEG C of dialysed overnight in 0.003 mol/l-0.01 mol/l pH5.5-7.8 NaCl solution in advance, to remove unnecessary salt ion.Then 100000 turns of 4 DEG C of centrifugal 1h, remove polymer.
3, the preparation of marking colloidal gold solution is waited: with 0.05 mol/l-0.3 mol/l K 2cO 3the pH value adjusting collaurum liquid is 7.5-10.0.Because colloidal gold solution may damage the electroplax of pH meter, therefore, when regulating pH, accurate pH test paper is adopted to be determined as suitable.
4, the determination of collaurum and the ratio of labelled protein consumption: according to the requirement of albumen to be marked, after collaurum is mixed up pH, packing 10 is managed, often pipe 1ml.It is 5 μ g/ml ~ 50 μ g/ml that labelled protein is done serial dilution with 0.005mol/l pH9.0 borate buffer solution, gets 1ml respectively, adds in above-mentioned gold size solution, mixing.Control tube only adds 1ml dilution.After 5min, in above-mentioned each pipe, add 0.1ml 10%NaCl solution, leave standstill 2h after mixing, observed result.Control tube (not adding protein) and add each pipe of quantity not sufficient with stable colloid gold of protein, all presents by the coagulation phenomenon of red stain indigo plant; And add protein content and meet or exceed the quantitative each pipe of minimum steady and still keep red constant.Stablize the red constant minimum enzyme protein dosage of 1ml colloidal gold solution, be the minimum amount of this protein of mark, in real work, suitably can increase by 10% ~ 20%.
5, the combination of collaurum and anti-CRISP1 monoclonal antibody: by colloidal gold solution with 0.05 mol/l-0.3 mol/l K 2cO 3adjust pH to 7.5-10.0, add the anti-CRISP1 monoclonal antibody solution of having dialysed, eddy mixer mixes, and after reaction 10min, adds stabilizing agent and precipitates to prevent collaurum to be polymerized.Conventional stabilizing agent is 5% hyclone (BSA) and 1% polyethylene glycol (molecular weight 20KD).The amount added: 5%BSA makes solution final concentration be 1%; 1% polyethylene glycol adds to 1/10 of total solution.
6, the purifying of colloid gold label albumen: the colloidal gold labeled monoclonal antibody compound prepared is at the centrifugal 15min of 900rpm/min, and careful sucking-off supernatant, sediment redissolves with containing the sucrose of 5% and the 0.002M borate buffer solution of 0.05% Tween-20.Centrifuge washing twice, is finally concentrated into 1/10,4 DEG C of preservations of original volume by compound.
Embodiment 4 prepares the CRISP1 test paper of quick diagnosis cheek cancer
Please refer to accompanying drawing 1, accompanying drawing 1 is the structural representation of the CRISP1 diagnose test paper of cheek cancer.This test paper is provided with base plate 1, base plate covers successively sample pad 2, gold size pad 3, cellulose nitrate rete 4 and absorbent paper layer 5.Described base plate 1 is PVC base plate, and saliva glass fibre inhaled by the material of sample pad 2.The making of gold size pad 3: by preparation-obtained for embodiment 3 golden labeling antibody solution specking on the glass fibre membrane that 1cm is wide, point sample amount is about 2ul/cm, 37 DEG C of dryings.The making of cellulose nitrate rete 4: by two anti-speckings on nitrocellulose membrane (NC film), as nature controlling line (C line).Using anti-CRISP1 polyclonal antibody specking distance nature controlling line 1cm place as p-wire (T line), point sample amount is about 1ul/cm.The detection threshold of described p-wire (T line) is 10-40 ng/ml.37 DEG C of dryings.Above-mentioned sample pad, gold size pad, cellulose nitrate rete, absorbent paper layer are assembled on base plate successively, are cut into the test strips that 4mm is wide, load in test card.
The detection of the CRISP1 test paper of embodiment 5 quick diagnosis cheek cancer
Please refer to accompanying drawing 2, accompanying drawing 2 is testing result schematic diagrames of the CRISP1 diagnose test paper of cheek cancer.
One, test paper detecting method:
1, the sample to be tested (saliva) getting 50ul is added in the S place, sample application zone of test strips;
2, in 10min postscript observed and recorded testing result.The result of observing after 20min is invalid.
Two, the judgement of testing result:
1, positive findings: please refer to accompanying drawing 2A, each appearance aubergine band on the p-wire T line and nature controlling line C line position of test strips.
, only on the nature controlling line C line of test strips, there is an aubergine band in 2, negative findings: please refer to accompanying drawing 2B.
3, null result: please refer to accompanying drawing 2C, there is not aubergine band in the nature controlling line C line of test strips.
Three, Cleaning Principle
Please refer to accompanying drawing 3, accompanying drawing 3 is testing process schematic diagrames of the CRISP1 diagnose test paper of cheek cancer.As shown in the figure, several salivas 6 drop in sample pad 2, because of chromatography effect, liquid flows along chromatography direction 7 to absorbent paper layer 5 direction, when flowing through gold size pad 3, gold labeling antibody just can be dissolved, and the CRISP1 in saliva is combined, forming gold mark compound, continuing reach, when flowing through T line (detection line) with liquid, the anti-CRISP1 polyclonal antibody of compound on T line is combined and condenses and develop the color, when flowing through C line (nature controlling line), compound and two anti-bindings and condense colour developing, as C line does not develop the color, it is invalid to show to detect.If T line develops the color, showing that in patient's saliva, CRISP1 content is more than or equal to 10-40ng/ml, is the positive, indicates the possibility suffering from cheek cancer, if T line does not develop the color, shows that in patient's saliva, CRISP1 content is normal.

Claims (1)

1. one kind is rich in the application of cysteine secretory protein 1 in the medicine equipment of preparation diagnosis cheek cancer, described medicine equipment is diagnose test paper or kit, the diagnosis sample of described medicine equipment is saliva, and the diagnosis threshold of described medicine equipment is that saliva is rich in cysteine secretory protein 1 concentration 40ng/ml.
CN201310191251.8A 2013-05-22 2013-05-22 New application of CRISP (cysteine-rich secretory protein)1 to medical instrument Expired - Fee Related CN103257241B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310191251.8A CN103257241B (en) 2013-05-22 2013-05-22 New application of CRISP (cysteine-rich secretory protein)1 to medical instrument

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310191251.8A CN103257241B (en) 2013-05-22 2013-05-22 New application of CRISP (cysteine-rich secretory protein)1 to medical instrument

Publications (2)

Publication Number Publication Date
CN103257241A CN103257241A (en) 2013-08-21
CN103257241B true CN103257241B (en) 2015-04-29

Family

ID=48961275

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310191251.8A Expired - Fee Related CN103257241B (en) 2013-05-22 2013-05-22 New application of CRISP (cysteine-rich secretory protein)1 to medical instrument

Country Status (1)

Country Link
CN (1) CN103257241B (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027178A1 (en) * 2001-03-16 2003-02-06 George Vasmatzis Methods and kits for determining a cancer diagnosis and prognosis
WO2007092713A2 (en) * 2006-02-02 2007-08-16 Trustees Of The University Of Pennsylvania Microfluidic system and method for analysis of gene expression in cell-containing samples and detection of disease
WO2008067065A2 (en) * 2006-10-19 2008-06-05 Shiv Srivastava Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
CA2693546A1 (en) * 2009-11-03 2011-05-03 Universite Laval Detection of human cysteine-rich secretory protein (crisp1) in semen and medical applications related thereto
US8658166B2 (en) * 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
CN102914658A (en) * 2012-10-24 2013-02-06 高维强 Application of CRISP3 protein on diagnosis and treatment of prostate cancer

Also Published As

Publication number Publication date
CN103257241A (en) 2013-08-21

Similar Documents

Publication Publication Date Title
CN104515859A (en) Hemoglobin, hemoglobin-haptoglobin composite and transferrin joint examination kit and preparation method and detection method thereof
WO2014132150A1 (en) Rapid identification of organisms in bodily fluids
CN103308682A (en) Kit for rapid lip cancer diagnosis
CN103308695A (en) Cysteine-rich secretory protein 1 (CRISP1) kit for cheek carcinoma diagnosis
CN103308692A (en) CRISP1 (Cysteine-Rich Secretory Protein 1) gold-labeled kit for rapid oral floor carcinoma diagnosis
CN103278644A (en) Gold-labelled CRISP (cysteine-rich secretory protein)1 kit for quickly diagnosing carcinoma of palate
CN103308691B (en) Application of secretory protein 1 rich in cysteine in preparation of product for diagnosing cheilocarcinoma
CN103257241B (en) New application of CRISP (cysteine-rich secretory protein)1 to medical instrument
CN103267863A (en) CRISP1 (cystein-rich secretory protein 1) test paper for quickly diagnosing carcinoma of maxillary sinus
CN103278629A (en) Gold-labelled kit for quickly diagnosing oropharynx carcinoma
CN103278645B (en) Application of gold-labelled test strip for quickly diagnosing carcinoma of lip
CN103257242B (en) Application of CRISP (cysteine-rich secretory protein)1 kit for diagnosing carcinoma of buccal mucosa
CN103267858B (en) Application of CRISP1 (Cysteine-Rich Secretory Protein 1) in preparing gold label test paper for diagnosing salivary gland carcinoma
CN103267860B (en) Application of CRISP1 (Cysteine-Rich Secretory Protein 1) in preparing kit for diagnosing jawbone carcinoma
CN103267861B (en) Application of cysteine-rich secretory protein 1 in manufacturing product for diagnosing palate carcinoma
CN103267856B (en) Application of kit for diagnosing jaw cancer
CN103293320B (en) Application of cysteine-rich secretory protein 1 (CRISP 1) in preparation of gingival cancer diagnosis products
CN103278646B (en) Application of gold-labelled cysteine-rich secretory protein (CRISP)1 kit for diagnosing mouth floor carcinoma
CN103257240B (en) Application of CRISP (cysteine-rich secretory protein)1 kit for diagnosing carcinoma of tongue
CN103267859B (en) Application of CRISP1 (cystein-rich secretory protein 1) test paper for diagnosing gingival carcinoma
CN103293319A (en) Gold-labeled test paper for rapidly diagnosing carcinoma jaw
CN103267848A (en) CRISP1 (cystein-rich secretory protein 1) kit for quickly diagnosing gingival carcinoma
CN203443962U (en) Rapid detection card for mycobacterium tuberculosis antibody
CN103257238B (en) Application of CRISP (cysteine-rich secretory protein)1 test paper for diagnosing carcinoma of maxillary sinus
CN103308694A (en) Gold-labeled kit for salivary gland carcinoma diagnosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: SHANGHAI TENTH PEOPLE'S HOSPITAL

Free format text: FORMER OWNER: SUZHOU MAERTAI NEW MATERIALS CO., LTD.

Effective date: 20150226

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 215434 SUZHOU, JIANGSU PROVINCE TO: 200072 PUTUO, SHANGHAI

TA01 Transfer of patent application right

Effective date of registration: 20150226

Address after: 200072 No. 301, Yanchang Road, Shanghai

Applicant after: Shanghai Tenth People's Hospital

Address before: 215434 room 19, business center, 730 North Ring Road, pontoon Town, Suzhou City, Jiangsu, Taicang

Applicant before: Suzhou Maertai New Material Co., Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150429

Termination date: 20190522